115 related articles for article (PubMed ID: 30064493)
1. Clinical significance of FBXO17 gene expression in high-grade glioma.
Du D; Yuan J; Ma W; Ning J; Weinstein JN; Yuan X; Fuller GN; Liu Y
BMC Cancer; 2018 Jul; 18(1):773. PubMed ID: 30064493
[TBL] [Abstract][Full Text] [Related]
2. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
3. Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors.
Tan Y; Mu W; Wang XC; Yang GQ; Gillies RJ; Zhang H
Eur J Radiol; 2019 Nov; 120():108609. PubMed ID: 31606714
[TBL] [Abstract][Full Text] [Related]
4. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
5. F-box protein 17 promotes glioma progression by regulating glycolysis pathway.
Deng C; Li H; Li Q
Biosci Biotechnol Biochem; 2022 Mar; 86(4):455-463. PubMed ID: 35044455
[TBL] [Abstract][Full Text] [Related]
6. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
[TBL] [Abstract][Full Text] [Related]
7. Correlation of high delta-like ligand 4 expression with peritumoral brain edema and its prediction of poor prognosis in patients with primary high-grade gliomas.
Qiu XX; Wang CH; Lin ZX; You N; Wang XF; Chen YP; Chen L; Liu SY; Kang DZ
J Neurosurg; 2015 Dec; 123(6):1578-85. PubMed ID: 26047413
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
[TBL] [Abstract][Full Text] [Related]
9. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.
Jang BS; Kim IA
Radiother Oncol; 2018 Aug; 128(2):245-253. PubMed ID: 29784449
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
[TBL] [Abstract][Full Text] [Related]
11. Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas.
Du W; Pang C; Wang D; Zhang Q; Xue Y; Jiao H; Zhan L; Ma Q; Wei X
PLoS One; 2015; 10(5):e0127976. PubMed ID: 26011451
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
[TBL] [Abstract][Full Text] [Related]
13. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
[TBL] [Abstract][Full Text] [Related]
14. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
[TBL] [Abstract][Full Text] [Related]
15. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
[TBL] [Abstract][Full Text] [Related]
16. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
[TBL] [Abstract][Full Text] [Related]
17. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
18. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
19. Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas.
He ZQ; Ke C; Al-Nahari F; Duan H; Guo CC; Wang Y; Zhang XH; Chen YS; Liu ZG; Wang J; Chen ZP; Jiang XB; Mou YG
J Neurooncol; 2017 Apr; 132(2):239-247. PubMed ID: 28078639
[TBL] [Abstract][Full Text] [Related]
20. Survival and low-grade glioma: the emergence of genetic information.
Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
